FARMACIA BARCELONETA SLP
Company details
- Active NIF/CIF: B55242929
-
Telephone: Not available
-
Date of last BORME entry: 10/06/2020
-
Sector: Manufacturing
-
Address: Carrer de Joan Maragall, 13, 17002 Girona, Girona, España See in map
-
Website: Not available
-
Featured products:
More information on FARMACIA BARCELONETA SLP
-
10/06/2020 | BORME act no.: 176207 | Register: GIRONACierre provisional de la hoja registral por revocación del NIF -
27/01/2020 | BORME act no.: 35037 | Register: GIRONACierre provisional hoja registral por baja en el índice de Entidades Jurídicas
-
10/09/2015 | BORME act no.: 370551 | Register: GIRONAConstitución
-
10/09/2015 | BORME act no.: 370551 | Register: GIRONANombramientos
Other information
The CIF assigned to FARMACIA BARCELONETA SLP is B55242929, and its commercial status is active. The company is engaged in economic activities classified under the CNAE 21 - Fabricación de productos farmacéuticos. Additionally, it is categorized with the SIC code 2834 - Productos químicos-farmacéuticos.
FARMACIA BARCELONETA SLP employs approximately Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Girona, and has 3 registration charges. The most recent announcement in Borme was published on 10/06/2020, while the last deposit of ordinary annual accounts corresponds to the year -.
To find out the contact information of FARMACIA BARCELONETA SLP, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about FARMACIA BARCELONETA SLP, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about FARMACIA BARCELONETA SLP comes from official data sources and is automatically updated every day.
Do you want to know more about FARMACIA BARCELONETA SLP??
Find out more about this company by consulting these reports:
